Spio-MR Imaging versus Double-Phase Spiral CT in Detecting Malignant Lesions of the Liver

Purpose: To assess the diagnostic performance of superparamagnetic iron oxide MR (SPIO-MR) imaging compared with double-phase spiral CT in detecting liver metastases and hepatocellular carcinoma. Material and Methods: Thirty-eight patients with a total of 144 malignant lesions of the liver were examined by CT and SPIO-MR. After definition of a gold standard by a panel of experts, the patient images were randomized and presented to a blinded jury of 5 independent observers whose task was to identify as many lesions as possible. the results were tested for statistical significance using multifactorial analysis of variance (α=5%). Results: SPIO-MR produced the highest detection rate and was significantly superior (p<0.05) to unenhanced MR imaging and double spiral-phase contrast-enhanced CT (DPS-CECT). Maximum performance in DPS-CECT was obtained during the portal venous contrast phase but was significantly inferior to SPIO-MR imaging. the scores for unenhanced CT and unenhanced MR were significantly lower than for the corresponding enhanced procedures. SPIO-MR imaging produced a higher incidence of false-positive findings (n=39). Conclusion: SPIO-MR produced a significantly better detection rate for malignant focal liver lesions compared with double-phase spiral DPS-CECT but was associated with a higher rate of false-positive findings.

[1]  T. Winter,et al.  MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions. , 1993, AJR. American journal of roentgenology.

[2]  M. C. Han,et al.  Characterization of focal hepatic tumors value of two‐phase scanning with spiral computed tomography , 1995, Cancer.

[3]  B. Hamm,et al.  Wertigkeit des leberspezifischen superparamagnetischen Kontrastmittels AMI-25 für die Detektion und Differentialdiagnose lebereigener Tumoren versus Metastasen , 1994 .

[4]  R Weissleder,et al.  Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. , 1988, Radiology.

[5]  T J Brady,et al.  Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. , 1987, Radiology.

[6]  C. Metz,et al.  Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. , 1990, AJR. American journal of roentgenology.

[7]  F. Long,et al.  Fast gradient echo MR imaging of the liver enhanced with superparamagnetic iron oxide. , 1997, Magnetic resonance imaging.

[8]  J.-W. Oestmann,et al.  ROC: Methodik zum Vergleich der diagnostischen Leistung bildgebender Verfahren , 1989 .

[9]  L. Hamberg,et al.  Detection of Focal Liver Lesions with Superparamagnetic Iron Oxide: Value of STIR and SE Imaging , 1994, Journal of computer assisted tomography.

[10]  R. Edelman,et al.  Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results. , 1989, AJR. American journal of roentgenology.

[11]  R. Murakami,et al.  Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. , 1995, Radiology.

[12]  G. Marchal,et al.  Focal liver lesions: fast T2-weighted MR imaging with half-Fourier rapid acquisition with relaxation enhancement. , 1996, Radiology.

[13]  R B Jeffrey,et al.  Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. , 1995, AJR. American journal of roentgenology.

[14]  R. Baron,et al.  Understanding and optimizing use of contrast material for CT of the liver. , 1994, AJR. American journal of roentgenology.

[15]  D. Khayat,et al.  Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. , 1994, Radiology.

[16]  A. Baert,et al.  Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. , 1989, AJR. American journal of roentgenology.

[17]  F. Terrier,et al.  Enhancement of Liver Hemangiomas on T1‐Weighted MR SE Images by Superparamagnetic Iron Oxide Particles , 1994, Journal of computer assisted tomography.

[18]  B. Marincek,et al.  Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. , 1995, Radiology.

[19]  H. Kugel,et al.  Prospective comparison of fast SE and GRASE sequences and echo planar imaging with conventional SE sequences in the detection of focal liver lesions at 1.0 T. , 1997, Journal of computer assisted tomography.

[20]  C. Hutchinson,et al.  Superparamagnetic iron oxide imaging of focal liver disease. , 1995, Clinical radiology.

[21]  S E Seltzer,et al.  Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. , 1995, Radiology.

[22]  P. Parizel,et al.  The influence of MR field strength on the detection of focal liver lesions with superparamagnetic iron oxide , 1997, European Radiology.

[23]  H E Rockette,et al.  Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. , 1996, AJR. American journal of roentgenology.

[24]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[25]  R. Nelson,et al.  Helical CT for detecting focal liver lesions in patients with breast carcinoma: comparison of noncontrast phase, hepatic arterial phase, and portal venous phase. , 1997, Journal of computer assisted tomography.

[26]  B. Hamm,et al.  Superparamagnetische Eisenpartikel: Klinische Ergebnisse in der MR-Diagnostik von Lebermetastasen , 1994 .

[27]  T J Brady,et al.  Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. , 1987, Radiology.

[28]  Y. Suto,et al.  Correlation between Chondroitin Sulfate Iron Colloid-Enhanced MR Imaging and the Histological Grade of Hepatocellular Carcinoma , 1995, Acta radiologica.

[29]  G. Adam,et al.  Superparamagnetische Eisenoxidpartikel : Welchen Stellenwert hat der T1-Effekt für die MR-Diagnostik fokaler Leberläsionen ? , 1996 .

[30]  T. Metens,et al.  Effects of ami‐25 on liver vessels and tumors on T1‐weighted turbo‐field‐echo images: Implications for tumor characterization , 1997, Journal of magnetic resonance imaging : JMRI.

[31]  P. Robinson,et al.  Hepatic lesion detection at MR imaging: a comparative study with four sequences. , 1997, Radiology.